 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
 |
 |
 |
 |
Phase: |
 |
Phase 3 |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1924 |
 |
 |
 |
 |
Age Group: |
 |
Adults Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
70: Cares for self, unable to perform normal activity or to do active work |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed IF you are interested in this trial, contact them as soon as possible, as there is a strict window of opportunity to join. Some of our members missed by a few days. |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
04/29/2012 |
 |
 |
 |
 |
Tumor Types: |
 |
Glioblastoma Multiforme |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
See Novocure for more information on this device! |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Less-Toxics |
 |
 |
 |
 |
Contact: |
 |
Thomas Chen MD, PHD USC Norris Cancer Center Contact: Lydia Wilson, NP 1441 Eastlake Avenue Los Angeles, CA 90033 USA Phone: 323-865-3945 Fax: (323)226-7833 E-mail: lydia.wilson@med.usc.edu Website: www.norriscancerhospital.com |
 |
 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is a combination of our internal ID and the official ID for the trial, if any.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
|
|